U.S. Emerging Osteoporosis Therapeutics Markets

 



This report gives detailed information about the U.S. osteoporosis market participants, revenue forecasts, market shares, projected prevalence of disease and therapeutic options, according to product class, namely estrogen replacement therapy, biphosphonates, calcitonin, selective estrogen receptor modulators and other emerging osteoporosis therapies. Key market and technology trends are discussed relative to the future of the market.

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

Table of Contents

U.S. Emerging Osteoporosis Therapeutics Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Emerging Osteoporosis Therapeutics Markets, IntroductionOverviewScope and SegmentationDisease Definition And PathogenesisTypes Of OsteoporosisRisk FactorsSymptomsDiagnosisPrevention And TreatmentCost Of Osteoporotic FracturesChallengesMarket DriversMarket RestraintsMarket DynamicsDemand AnalysisMarket and Technology TrendsStrategic RecommendationsStrategies OverviewStrategic Recommendations for Market Challenge 1Strategic Recommendations for Market Challenge 2Strategic Recommendations for Market Challenge 3Frost & Sullivan Market Engineering AwardsTechnology Innovation Award: NPS PharmaceuticalsStrategic Alliance Innovation Award: Emisphere Technologies Technology Leadership Award: Eli Lilly And CompanyBusiness Development Strategy Award: The Alliance For Better Bone HealthProduct Line Strategy Award: Wyeth U.S. Emerging Osteoporosis Therapeutics Markets, Estrogen Replacement Therapy MarketOverviewIntroductionMarket DriversMarket RestraintsMarket Engineering AnalysisForecasts and TrendsRevenue ForecastsPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingU.S. Emerging Osteoporosis Therapeutics Markets, Biphosphonates MarketOverviewIntroductionMarket DriversMarket RestraintsMarket Engineering AnalysisForecasts and TrendsRevenue ForecastsPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingU.S. Emerging Osteoporosis Therapeutics Markets, Selective Estrogen Receptor Modulator MarketOverviewIntroductionMarket DriversMarket RestraintsMarket Engineering AnalysisForecasts and TrendsRevenue ForecastsPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingU.S. Emerging Osteoporosis Therapeutics Markets, Calcitonin MarketOverviewIntroductionMarket DriversMarket RestraintsMarket Engineering AnalysisForecasts and TrendsRevenue ForecastsPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis-ExistingProduct Analysis-EmergingU.S. Emerging Osteoporosis Therapeutics Markets, Other Emerging Osteoporosis Therapeutics MarketOverviewIntroductionMarket Engineering AnalysisForecasts and TrendsRevenue ForecastsPricing TrendsCompetitive AnalysisCompetitive StructureProduct Analysis - Forteo and PreosProduct Analysis- Oral PTH and Growth Hormone Releasing Factors




Related Research

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.